
This study examined changes in attentional performance in patients with schizophrenia during the 2 months after initiating treatment with quetiapine fumarate. Prior to treatment, attentional performance in patients with schizophrenia (n = 10) was significantly (p < 0.01) worse than in matched controls (n = 12). During treatment with quetiapine, performance in patients with schizophrenia improved, and by 2 months, did not differ significantly from that of the controls. These results suggest that quetiapine produces a significant improvement in attentional functioning in patients with schizophrenia.
Adult, Male, Psychiatric Status Rating Scales, Dibenzothiazepines, Discrimination Learning, Quetiapine Fumarate, Treatment Outcome, Double-Blind Method, Schizophrenia, Humans, Attention, Female, Schizophrenic Psychology, Psychomotor Performance, Antipsychotic Agents
Adult, Male, Psychiatric Status Rating Scales, Dibenzothiazepines, Discrimination Learning, Quetiapine Fumarate, Treatment Outcome, Double-Blind Method, Schizophrenia, Humans, Attention, Female, Schizophrenic Psychology, Psychomotor Performance, Antipsychotic Agents
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 51 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
